In the emulation of SURPASS-CVOT comparing tirzepatide to dulaglutide in patients at high cardiovascular risk (Table 2 and Supplementary Table 19), the estimated HR was 0.83 (95% CI 0.69 to 1.01) compared to the trial estimates of HR 0.92 (95% CI 0.83 to 1.01)
While used primarily for weight loss, tirzepatide can address a whole host of other health concerns, including: Dementia or other cognitive disorders Heart disease Arthritis Depression Cancer Kidney disease Liver disease Inflammation We recommend consulting your InterveneMD provider to learn how tirzepatide can support your wellness goals
Entre los medicamentos de GLP-1 disponibles actualmente en el mercado para la prdida de peso se incluyen: Inyecciones semanales de semaglutida (Wegovy) Comprimidos diarios de semaglutida (Wegovy) Inyecciones semanales de tirzepatida (Zepbound) Inyecciones diarias de liraglutida (Saxenda) Cmo funcionan los GLP-1
Skipping Meals Entirely It can be tempting to skip meals when hunger is low, but doing so regularly may worsen fatigue, dizziness, and nutrient deficiencies
Reduced Sweating (Anhidrosis): Some individuals with diabetes experience reduced sweating, making it difficult to cool down in hot weather